Counterfeit retatrutide weight-loss drug leaves Australian patients in acute liver failure
Australian patients who took counterfeit retatrutide-based weight-loss injections sold through unregulated channels have been hospitalised with acute liver failure. The Therapeutic Goods Administration is urging the public to use only approved, prescribed products.
According to ABC News Australia, at least two Australian patients who bought counterfeit retatrutide-labelled weight-loss injections for cash through beauticians were admitted to intensive care with acute liver failure following the second dose. A patient identified as Megan Hancocks shared her experience with the broadcaster.
The Therapeutic Goods Administration (TGA) stressed that retatrutide is not yet approved for any indication in Australia and that there is no quality assurance for products obtained through unregulated channels. The TGA, customs and the federal police are jointly investigating supply sources.
In the international context, shortages of approved GLP-1 analogues are making it easier for counterfeit and compounded products to enter the market. Australian medical associations urged patients to use only prescribed products purchased through pharmacies.
Read next
Israel strikes south Lebanon again as families flee north
Israeli airstrikes hit the Nabatieh district of southern Lebanon just hours after the deadliest day of Israeli raids, as families in the region flee their homes and head north.
Australian minister won't commit to delaying NDIS exit if supports aren't ready
Graphs show why the DR Congo Ebola outbreak could be the worst in history
North Korea's Kim tells Putin he is proud of strong ties, state media reports
